Metraipolis › archive › dc_eacd7144733e

Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk Outpatients — Europe PMC PMID:42019019

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42019019
DOI
10.1056/nejmoa2502457
License (as archived)
solo-consultazione
Archived
2026-11-03T12:40:50.011Z
SHA-256 of the archived text
269b8175097d7374a4b20a31a9df71ba10d783cbb02ad1888a39aaee30d9101a
Stable URL of this page
https://metraipolis.com/documento/dc_eacd7144733e

How to cite

Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk Outpatients — Europe PMC PMID:42019019 — Europe PMC (en), https://europepmc.org/article/MED/42019019 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eacd7144733e (Metraipolis archive dc_eacd7144733e, sha256 269b8175097d7374a4b20a31a9df71ba10d783cbb02ad1888a39aaee30d9101a)
BibTeX
@misc{dceacd7144733e,
  title = {Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk Outpatients — Europe PMC PMID:42019019},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42019019},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eacd7144733e; sha256 269b8175097d7374a4b20a31a9df71ba10d783cbb02ad1888a39aaee30d9101a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42019019. Agents can read the archived copy with the MCP tool read_document.